Aura Biosciences logo

Aura Biosciences Share Price Today

(NASDAQ: AURA)

Aura Biosciences share price is $7.49 & ₹651.40 as on 6 Mar 2025, 2.30 'hrs' IST

$7.49

-0.01

(-0.13%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Aura Biosciences share price in Dollar and Rupees. Guide to invest in Aura Biosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Aura Biosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Aura Biosciences share price movements

  • Today's Low: $7.39
    Today's High: $7.59

    Day's Volatility :2.57%

  • 52 Weeks Low: $6.63
    52 Weeks High: $12.38

    52 Weeks Volatility :46.44%

Aura Biosciences (AURA) Returns

PeriodAura Biosciences, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-9.42%
2.1%
0.0%
6 Months
-4.09%
-4.1%
0.0%
1 Year
-16.67%
2.2%
0.0%
3 Years
-58.84%
11.8%
-11.6%

Aura Biosciences (AURA) Key Statistics

in dollars & INR

Previous Close
$7.5
Open
$7.565
Today's High
$7.585
Today's Low
$7.39
Market Capitalization
$374.6M
Today's Volume
$39.3K
52 Week High
$12.3782
52 Week Low
$6.63
Revenue TTM
$0.0
EBITDA
$-91.8M
Earnings Per Share (EPS)
$-1.73
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-50.99%

How to invest in Aura Biosciences Stock (AURA) from India?

It is very easy for Indian residents to invest directly in Aura Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aura Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aura Biosciences or AURA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aura Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aura Biosciences shares which would translate to 0.116 fractional shares of Aura Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aura Biosciences, in just a few clicks!

Returns in Aura Biosciences (AURA) for Indian investors in Rupees

The Aura Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aura Biosciences investment value today

Current value as on today

₹88,185

Returns

₹11,815

(-11.82%)

Returns from Aura Biosciences Stock

₹16,778 (-16.78%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Aura Biosciences (AURA)

-19%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Aura Biosciences Stock from India on INDmoney has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Aura Biosciences

  • Matrix Capital Management Company, LLC

    13.86%

  • Adage Capital Partners Gp LLC

    9.77%

  • Eventide Asset Management, LLC

    8.17%

  • BlackRock Inc

    7.11%

  • Medicxi Ventures Management (Jersey) Ltd

    6.09%

  • Long Focus Capital Management, LLC

    5.08%

Analyst Recommendation on Aura Biosciences

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Aura Biosciences(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Aura Biosciences Stock (AURA)

What analysts predicted

Upside of 191.5%

Target:

$21.83

Current:

$7.49

Insights on Aura Biosciences Stock (Ticker Symbol: AURA)

  • AURA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 79.0%
  • AURA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 108.2%

Aura Biosciences Technicals Summary

Sell

Neutral

Buy

Aura Biosciences is currently in a neutral trading position according to technical analysis indicators.

Aura Biosciences (AURA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Aura Biosciences, Inc. logo
-6.25%
-4.09%
-16.67%
-58.84%
-49.32%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Aura Biosciences, Inc. logo
NA
NA
NA
0.0
-0.51
-0.3
NA
3.51
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Aura Biosciences, Inc. logo
Buy
$374.6M
-49.32%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Aura Biosciences

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmette"guérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.
Organization
Aura Biosciences
Employees
88
CEO
Dr. Elisabet de los Pinos Ph.D.
Industry
Healthcare

Management People of Aura Biosciences

NameTitle
Dr. Elisabet de los Pinos Ph.D.
Founder, CEO, President & Director
Ms. Amy Elazzouzi
Interim Principal Financial Officer & Interim Principal Accounting Officer
Dr. Mark Plavsic D.V.M., Ph.D.
Chief Technology Officer
Mr. Conor Kilroy
General Counsel & Secretary
Mr. Patrick Nealon
Senior Vice President of Clinical Development Operations
Dr. Anthony Daniels M.D.
VP & Therapeutic Area of Head Ocular Oncology
Dr. Richard Mountfield Ph.D.
Senior Vice President of Regulatory Affairs & Quality
Dr. Jill J. Hopkins M.D.
Chief Medical Officer & President of Research and Development
Dr. Sabine Brookman-May
Senior VP & Therapeutic Area Head of Urologic Oncology

Important FAQs about investing in AURA Stock from India :

What is Aura Biosciences share price today?

Aura Biosciences share price today stands at $7.49, Open: $7.57 ; Previous Close: $7.50 ; High: $7.59 ; Low: $7.39 ; 52 Week High: $12.38 ; 52 Week Low: $6.63.

The stock opens at $7.57, after a previous close of $7.50. The stock reached a daily high of $7.59 and a low of $7.39, with a 52-week high of $12.38 and a 52-week low of $6.63.

Can Indians buy Aura Biosciences shares?

Yes, Indians can invest in the Aura Biosciences (AURA) from India.

With INDmoney, you can buy Aura Biosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Aura Biosciences at zero transaction cost.

How can I buy Aura Biosciences shares from India?

It is very easy to buy Aura Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aura Biosciences (AURA) be purchased?

Yes, you can buy fractional shares of Aura Biosciences with INDmoney app.

What are the documents required to start investing in Aura Biosciences stocks?

To start investing in Aura Biosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Aura Biosciences Stock (AURA)?

Today’s highest price of Aura Biosciences (AURA) is $7.59.

Today’s lowest price of Aura Biosciences (AURA) is $7.39.

What is today's market capitalisation of Aura Biosciences?

Today's market capitalisation of Aura Biosciences AURA is 374.6M

What is the 52 Week High and Low Range of Aura Biosciences Stock (AURA)?

  • 52 Week High

    $12.38

  • 52 Week Low

    $6.63

What are the historical returns of Aura Biosciences (AURA)?

  • 1 Month Returns

    -6.25%

  • 3 Months Returns

    -4.09%

  • 1 Year Returns

    -16.67%

  • 5 Years Returns

    -49.32%

Who is the Chief Executive Officer (CEO) of Aura Biosciences ?

Dr. Elisabet de los Pinos Ph.D. is the current Chief Executive Officer (CEO) of Aura Biosciences.